Wednesday, May 20, 2026
HomeTagsArteraAI

Tag: ArteraAI

Healthcare

New Data Validating the First AI-Based Biomarker to Stratify Risk of Metastasis in Radical Prostatectomy Patients with Biochemical Recurrence+

ArteraAI, the developer of multimodal artificial intelligence-based prognostic and predictive cancer tests, announced the validation of its first multimodal artificial intelligence (MMAI) digital pathology-based...
Healthcare

ArteraAI Announced as the First-and-Only Predictive Test for Therapy Personalization in the 2024 NCCN Guidelines® for Prostate Cancer

The multimodal artificial intelligence (MMAI) test is the first AI-enabled tool recognized in national guidelines for both predictive and prognostic performance ArteraAI, the developer of multimodal artificial...
Healthcare

ArteraAI Secures $20 Million in Funding to Further Personalize Cancer Therapy With Multimodal AI

The funding will support the international expansion and commercial growth of the company and its first-of-its-kind test ArteraAI, the developer of multimodal artificial intelligence (MMAI)...

Recent Published

About Us

Discover the future of artificial intelligence at AITech365. Explore the latest AI news, delve into insightful interviews with industry experts, and stay informed about the most exciting and trending topics shaping the world of AI.

Latest

Popular

Quick Link

© 2026 AITech365. All Rights Reserved. Website Undertaking: Data Demand